Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD
Authors
Keywords
-
Journal
Clinical Journal of the American Society of Nephrology
Volume -, Issue -, Pages CJN.15291219
Publisher
American Society of Nephrology (ASN)
Online
2020-07-22
DOI
10.2215/cjn.15291219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
- (2017) Steven Fishbane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials
- (2017) Nicole U Stoffel et al. Lancet Haematology
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
- (2016) Valentin David et al. KIDNEY INTERNATIONAL
- Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
- (2016) Carlo A. Gaillard et al. PLoS One
- A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
- (2015) Geoffrey A. Block et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women
- (2015) D. Moretti et al. BLOOD
- A randomized trial of intravenous and oral iron in chronic kidney disease
- (2015) Rajiv Agarwal et al. KIDNEY INTERNATIONAL
- Identification of erythroferrone as an erythroid regulator of iron metabolism
- (2014) Léon Kautz et al. NATURE GENETICS
- FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
- (2014) I. C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
- (2013) Myles Wolf et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice
- (2013) Erica L Clinkenbeard et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Hematologic Manifestations of Systemic Disease (Including Iron Deficiency, Anemia of Inflammation and DIC)
- (2013) Char M. Witmer PEDIATRIC CLINICS OF NORTH AMERICA
- Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
- (2011) E. G. Farrow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis
- (2010) D. Girelli et al. HAEMATOLOGICA
- Immunoassay for human serum hepcidin
- (2008) T. Ganz et al. BLOOD
- Iron Indices in Chronic Kidney Disease in the National Health and Nutritional Examination Survey 1988-2004
- (2008) S. Fishbane et al. Clinical Journal of the American Society of Nephrology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started